IDIBAPS, newly reaccredited as an institute for health research by the Carlos III Health Institute
IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019.
IDIBAPS successfully and positively achieved its first reaccreditation in 2014, and its second in 2019.
On 27 June 2024, a social return event was held at the TV3 facilities, thanking the public for the television marathon devoted to cancer.
A study by the Clínic-IDIBAPS presents the new preg-MEDAS questionnaire, which measures adherence to the Mediterranean diet in pregnant women. The st1
The investiture ceremony took place on 18 June at the University of Toulouse III - Paul Sabatier.
Head of the IDIBAPS Liver vascular biology research group, his research focuses on the study of hepatic vascular pathophysiology in acute and chronic1
Researchers from the Clínic-IDIBAPS have taken part in a study that provides new information on the mechanisms involved in idiopathic inflammatory my1
Researchers at the Clínic-IDIBAPS coordinated a study published in Blood Cancer Journal in which a new 3D system was developed from patient samples t1
Dr. Llovet (Clínic-IDIBAPS) and Dr. Bustelo (CSIC-University of Salamanca) coordinate the ASPIRE-AECC project, which includes 15 hospitals to conduct1
The stemTIME project, led by Dr. Silvia Affo from IDIBAPS, investigates how cancer stem cells influence the tumor and immune microenvironment in intr1
A study published recently in the journal Clinical Cancer Research identified biomarkers that can predict the response to CAR T-cell therapy targetin1